FDA Inspection 1010212 — Delille Oxygen Company
The FDA completed an inspection of Delille Oxygen Company on April 12, 2017 in Columbus, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 12, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Columbus, OH (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 3569 | 21 CFR 211.89 | Quarantine of Rejected Components et. al. |